Email
Print
Levofloxacin Market Overview
Levofloxacin Market is forecast to reach $1.9 Billion by 2025, growing at a CAGR of 4.7% during the forecast period 2020-2025. Levofloxacin is an antibiotic marketed with a brand name Levaquin used for the destruction of bacteria inside the body. The mechanism of levofloxacin and other fluoroquinolone antimicrobials involves inhibition of bacterial topoisomerase IV and DNA gyrase. It is an injectable drug and is also marketed in tablet form. This drug is used for the diagnosis of pneumonia, acute bacterial sinusitis, chronic prostatitis, urinary tract infection and others. It is indicated for inhalational anthrax (post-exposure) to reduce the incidence or progression of disease exposure to aerosolized Bacillus anthracis. Budesonide and fluticasone are the replacement of levofloxacin drug.
Key Takeaways
- Rising government initiatives with an objective of improving awareness about diagnosis and treatment of pneumonia and similar infections is expected to aid growth of the market.
- Rising number of hospitals and retail pharmacies are set to aid the growth of levofloxacin market.
- APAC region is estimated to record the fastest growth rate during the forecast period 2020-2025.
By Indication Type - Segment Analysis
In 2019, Skin Infection segment dominated the Levofloxacin market in terms of revenue. The segment is estimated to grow at a CAGR of 2.8%. Levofloxacin is mostly used in skin infections as it is indicated for the treatment of complicated skin and skin structure infections due to methicillin-susceptible Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, or Proteus mirabilis and others. Skin infections include abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections and others.
By Sales Channel Type - Segment Analysis
In 2019, Hospital Pharmacy segment dominated the Levofloxacin market in terms of revenue. As hospital pharmacies holds stock at a larger range of medications, including more specialized and investigational medications. It contains all the forms of dosage and guides in proper usage of levofloxacin.
Geography - Segment Analysis
Based on the geography the Levofloxacin market is covered globally viz North America, South America, Europe, Asia Pacific (APAC) and Rest of World (ROW). Market in North America accounts for major share of 44% in terms of revenue and is projected to maintain its position over the forecast period 2020-2025. Rising number of government initiatives with an objective of improving awareness about diagnosis. Asia Pacific market in estimated to register highest CAGR in terms of revenue over the forecast period 2020-2025, owing to the major expansion in manufacturing pharmacies.
Market Drivers – Levofloxacin Market
- Growing Incidences of Bacterial Infections
The growth of bacteria inside the body is affecting organs with body like infections related to sinuses, skin, lungs, ears, airways, bones, and others. The growth of urinary infection is increasing which is leading the growth of the market.
Challenges – Levofloxacin Market
- Side Effects
Levofloxacin causes side effects like tendon problems, nerve damage, serious mood or behavior changes, or low blood sugar, numbness, weakness, tingling, burning pain, muscle weakness, breathing problem and others that may be serious or even cause death which could restrain the growth of the market.
Levofloxacin industry outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Levofloxacin Industry. In 2019, Levofloxacin market share is consolidated by the top ten players present in the market. Levofloxacin top 10 companies include Aden Healthcare, Allenge India Pharma, Alna Biotech Private Limited, Bestochem, Divine Savior Healthcare, Dr Reddys Laboratory Ltd, Glenmark Pharmaceutical, Lupin Pharmaceuticals, Inc, Pax Healthcare, Zydus Cadila.
1. Levofloxacin Market - Overview
1.1 Definitions and Scope
2. Levofloxacin Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Levofloxacin Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Levofloxacin Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Levofloxacin Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Levofloxacin Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Levofloxacin Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Levofloxacin Market - By Product (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Levofloxacin Market - By Type (Market Size -$Million / $Billion)
10. Levofloxacin - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Pneumonia
10.3.2 Skin Infection
10.3.3 Kidney Infection
10.3.4 Bladder Infection
11. Levofloxacin- By Geography (Market Size -$Million / $Billion)
11.1 Levofloxacin Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Levofloxacin- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Levofloxacin- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Levofloxacin - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Levofloxacin - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Levofloxacin Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Levofloxacin Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Levofloxacin Market - Key Company List by Country Premium
15. Levofloxacin Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Aden Healthcare
15.3 Allenge India Pharma
15.4 Alna Biotech Private Limited
15.5 Bestochem
15.6 Divine Savior Healthcare
15.7 Dr Reddys Laboratory Ltd
15.8 Glenmark Pharmaceutical
15.9 Lupin Pharmaceuticals, Inc
15.10 Pax Healthcare
15.11 Zydus Cadila
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Levofloxacin Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Levofloxacin Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Levofloxacin Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Levofloxacin Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Levofloxacin Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Levofloxacin Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Levofloxacin Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Levofloxacin Market - By Product (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Levofloxacin Market - By Type (Market Size -$Million / $Billion)
10. Levofloxacin - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Pneumonia
10.3.2 Skin Infection
10.3.3 Kidney Infection
10.3.4 Bladder Infection
11. Levofloxacin- By Geography (Market Size -$Million / $Billion)
11.1 Levofloxacin Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Levofloxacin- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Levofloxacin- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Levofloxacin - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Levofloxacin - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Levofloxacin Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Levofloxacin Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Levofloxacin Market - Key Company List by Country Premium
15. Levofloxacin Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Aden Healthcare
15.3 Allenge India Pharma
15.4 Alna Biotech Private Limited
15.5 Bestochem
15.6 Divine Savior Healthcare
15.7 Dr Reddys Laboratory Ltd
15.8 Glenmark Pharmaceutical
15.9 Lupin Pharmaceuticals, Inc
15.10 Pax Healthcare
15.11 Zydus Cadila
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Levofloxacin Market - Appendix16.1 Abbreviations
16.2 Sources
17. Levofloxacin Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
LIST OF FIGURES
1.US Levofloxacin Market Revenue, 2023-2030 ($M)2.Canada Levofloxacin Market Revenue, 2023-2030 ($M)
3.Mexico Levofloxacin Market Revenue, 2023-2030 ($M)
4.Brazil Levofloxacin Market Revenue, 2023-2030 ($M)
5.Argentina Levofloxacin Market Revenue, 2023-2030 ($M)
6.Peru Levofloxacin Market Revenue, 2023-2030 ($M)
7.Colombia Levofloxacin Market Revenue, 2023-2030 ($M)
8.Chile Levofloxacin Market Revenue, 2023-2030 ($M)
9.Rest of South America Levofloxacin Market Revenue, 2023-2030 ($M)
10.UK Levofloxacin Market Revenue, 2023-2030 ($M)
11.Germany Levofloxacin Market Revenue, 2023-2030 ($M)
12.France Levofloxacin Market Revenue, 2023-2030 ($M)
13.Italy Levofloxacin Market Revenue, 2023-2030 ($M)
14.Spain Levofloxacin Market Revenue, 2023-2030 ($M)
15.Rest of Europe Levofloxacin Market Revenue, 2023-2030 ($M)
16.China Levofloxacin Market Revenue, 2023-2030 ($M)
17.India Levofloxacin Market Revenue, 2023-2030 ($M)
18.Japan Levofloxacin Market Revenue, 2023-2030 ($M)
19.South Korea Levofloxacin Market Revenue, 2023-2030 ($M)
20.South Africa Levofloxacin Market Revenue, 2023-2030 ($M)
21.North America Levofloxacin By Application
22.South America Levofloxacin By Application
23.Europe Levofloxacin By Application
24.APAC Levofloxacin By Application
25.MENA Levofloxacin By Application
26.Alna Biotech Private Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Allenge India Pharma, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bestochem, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Divine Savior Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Glenmark Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Pax Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Aden Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Lupin Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Dr Reddys Laboratory Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Zydus Cadila, Sales /Revenue, 2015-2018 ($Mn/$Bn)